NY State Senate Bill 2011-S1834

Senate Bill S1834

2011-2012 Legislative Session

Prohibits sale or distribution of any product containing a synthetic cannabinoid; establishes a defense of lack of knowledge of the content of such product

download bill text pdf

Archive: Last Bill Status - In Senate Committee Rules Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jun 21, 2012	committed to rules
Mar 14, 2012	advanced to third reading
Mar 13, 2012	2nd report cal.
Mar 12, 2012	1st report cal.326
Mar 07, 2012	print number 1834a
Mar 07, 2012	amend and recommit to alcoholism and drug abuse
Jan 04, 2012	referred to alcoholism and drug abuse returned to senate died in assembly
May 09, 2011	referred to economic development delivered to assembly passed senate
Mar 30, 2011	advanced to third reading
Mar 29, 2011	2nd report cal.
Mar 28, 2011	1st report cal.263
Feb 23, 2011	committee discharged and committed to alcoholism and drug abuse
Jan 13, 2011	referred to consumer protection

Votes

- May 9, 2011 - Floor Vote
  S1834
  
  60
  
  Aye
  
  1
  
  Nay
  
  0
  
  Absent
  
  1
  
  Excused
  
  0
  
  Abstained
  - - Floor Vote: May 9, 2011
      
      aye (60)
      
      Adams
      
      Addabbo Jr.
      
      Alesi
      
      Avella
      
      Ball
      
      Bonacic
      
      Breslin
      
      Carlucci
      
      DeFrancisco
      
      Diaz
      
      Dilan
      
      Espaillat
      
      Farley
      
      Flanagan
      
      Fuschillo
      
      Gallivan
      
      Gianaris
      
      Golden
      
      Griffo
      
      Grisanti
      
      Hannon
      
      Hassell-Thompson
      
      Huntley
      
      Johnson
      
      Kennedy
      
      Klein
      
      Krueger
      
      Kruger
      
      LaValle
      
      Lanza
      
      Larkin
      
      Libous
      
      Little
      
      Marcellino
      
      Martins
      
      Maziarz
      
      McDonald
      
      Montgomery
      
      Nozzolio
      
      O'Mara
      
      Oppenheimer
      
      Parker
      
      Peralta
      
      Ranzenhofer
      
      Ritchie
      
      Rivera
      
      Robach
      
      Saland
      
      Sampson
      
      Savino
      
      Serrano
      
      Seward
      
      Skelos
      
      Smith
      
      Squadron
      
      Stavisky
      
      Stewart-Cousins
      
      Valesky
      
      Young
      
      Zeldin
      
      nay (1)
      
      Duane
      
      excused (1)
      
      Perkins
  Mar 12, 2012 - Committee Vote
  S1834
  
  6
  
  Aye
  
  0
  
  Nay
  
  0
  
  Aye with Reservations
  
  0
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  - - Committee Vote: Mar 12, 2012
      
      aye (6)
      
      Bonacic
      
      Breslin
      
      Hannon
      
      Huntley
      
      Klein
      
      McDonald
  Mar 28, 2011 - Committee Vote
  S1834
  
  6
  
  Aye
  
  0
  
  Nay
  
  0
  
  Aye with Reservations
  
  0
  
  Absent
  
  0
  
  Excused
  
  0
  
  Abstained
  - - Committee Vote: Mar 28, 2011
      
      aye (6)
      
      Bonacic
      
      Breslin
      
      Hannon
      
      Huntley
      
      Klein
      
      McDonald

Bill Amendments

Original

A (Active)

co-Sponsors

View additional co-sponsors

2011-S1834 - Details

See Assembly Version of this Bill:: A7231
Current Committee:: Senate Rules
Law Section:: General Business Law
Laws Affected:: Add §391-r, Gen Bus L
Versions Introduced in Other Legislative Sessions:: 2009-2010: S7081
2013-2014: A5889

2011-S1834 - Summary

Prohibits sale or distribution of any product containing a synthetic cannabinoid; defines the chemical compounds which constitute a synthetic cannabinoid; imposes a civil penalty of not more than $500 for a violation thereof; creates defenses based on over the counter drugs approved by the federal food and drug administration or lack of knowledge that the product contained a synthetic cannabinoid.

2011-S1834 - Sponsor Memo

                                BILL NUMBER:S1834

TITLE OF BILL:
An act to amend the general business law, in relation to prohibiting
the sale or distribution of products containing a synthetic
cannabinoid

PURPOSE:
To prohibit the sale or distribution of any product containing a
synthetic cannabinoid.

SUMMARY OF PROVISIONS:
Section One - The General Business Law is amended by adding a new
section 391-q to define a "synthetic cannabinoid" and prohibits the
sale, offering or gift of any products containing such.  Sets forth a
civil penalty for violations of this section. Creates a defense for
persons who unknowingly sell, offer or give away products containing a
synthetic cannabinoid if such knowledge was not reasonably
discoverable.

Section Two - Sets forth the effective date.

EXISTING LAW:
New York State Law does not ban the sale or gift of the herb-like
products that contain synthetic cannabinoids often known as K2, Spike
99, Spice, Yucatan Fire, Genie, Zohai and many others.

JUSTIFICATION:
Many recent news reports have brought to light the use of a legal
herb-like product that is laced with a synthetic cannabinoid that is
being smoked by individuals, including teens, as "fake weed." While
producing a marijuana-like high, dangerous side effects reported
include hallucinations, vomiting, agitation, increased heart rate,
elevated blood pressure and other adverse conditions.

This product, known as K2, Spike 99, Spice, Yucatan Fire, Genie or
Zohai and many others, can often be legally purchased in head shops,
smoke shops, tobacco shops or novelty shops. It can also be legally
purchased by mail or on the Internet. In fact, the product is often
marketed as incense or potpourri and on average sells for $30 to $40
per three gram bag. This price is comparable to what an individual
would pay on the street for the illegal substance marijuana.

Even more disturbing is that this type of synthetic cannabinoid has
never been tested for safety in humans as it was created for
experimental use in animals and cell cultures. In fact, these
synthetic cannabinoids have a chemical structure that is shared with
many cancer-causing agents.

The United States Drug Enforcement Administration (DEA) has issued
intelligence alert bulletins in regard to these substances. In
addition, the chemical compounds outlined in this legislation are on
the DEA's Office of Diversion Control's list of "Drugs and Chemicals
of Concern."


While the synthetic ingredients in these herb-like products which
mimic those of the illegal drug marijuana are banned throughout much
of Europe, bans are only beginning to take place in the United States.
Legislation banning these products recently was signed into law in
Kansas making it the first state in the nation to ban this type of
dangerous product. Legislation is also pending in Kentucky, Missouri
and Tennessee as of March 2010.

LEGISLATIVE HISTORY:
2010:  S.7081A - Reported out of Consumer Protection; Committed to
Codes

FISCAL IMPLICATIONS:
None.

EFFECTIVE DATE:
This act shall take effect on the sixtieth day after it shall have
become a law.

2011-S1834 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  1834

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                            January 13, 2011
                               ___________

Introduced  by Sen. FLANAGAN -- read twice and ordered printed, and when
  printed to be committed to the Committee on Consumer Protection

AN ACT to amend the general business law, in relation to prohibiting the
  sale or distribution of products containing a synthetic cannabinoid

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The general business law is amended by adding a new section
391-r to read as follows:
  S  391-R.  SALE  OR  DISTRIBUTION  OF  PRODUCTS CONTAINING A SYNTHETIC
CANNABINOID. 1. FOR THE PURPOSES OF THIS  SECTION,  "SYNTHETIC  CANNABI-
NOID" SHALL MEAN ANY OF THE FOLLOWING CHEMICAL COMPOUNDS:
  (A)   CP   47.497   AND   HOMOLOGUES:  2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]
-5-(2-METHYLOCTAN-2-YL)PHENOL);
  (B) HU-210: [(6AR,  10AR)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-  (2-METHY-
LOCTAN-2-YL)-6A,7,10, 10A-TETRAHYDROBENZO[C] CHROMEN-1-OL)];
  (C)     HU-211:     (DEXANABINOL,     (6AS,    10AS)-9-(HYDROXYMETHYL)
-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-6A,7,10,     10A-TETRAHYDROBENZO[C]
CHROMEN-1-OL);
  (D) JWH-O18: 1-PENTYL-3-(1-NAPHTHOYL)INDOLE; OR
  (E) JWH-O73: 1-BUTYL-3-(1-NAPHTHOYL)INDOLE.
  2.    NO  PERSON, FIRM, CORPORATION, PARTNERSHIP, ASSOCIATION, LIMITED
LIABILITY COMPANY OR OTHER ENTITY SHALL SELL,  OFFER  TO  SELL  OR  GIVE
AWAY,  AS  EITHER  A  RETAIL  OR WHOLESALE PROMOTION, ANY PRODUCT, WHICH
CONTAINS A SYNTHETIC CANNABINOID, WHICH MAY ALSO BE REFERRED TO  AS  K2,
SPIKE  99,  YUCATAN FIRE, SPICE, GENIE OR ZOHAI, EXCEPT AS AUTHORIZED BY
SUBDIVISION THREE OF THIS SECTION.
  3.  NOTHING  IN  THIS   SECTION   SHALL   APPLY   TO   NONPRESCRIPTION
OVER-THE-COUNTER  DRUGS  APPROVED  OR  REGULATED BY THE FEDERAL FOOD AND
DRUG ADMINISTRATION.
  4. ANY PERSON, FIRM, CORPORATION,  PARTNERSHIP,  ASSOCIATION,  LIMITED
LIABILITY  COMPANY  OR OTHER ENTITY THAT VIOLATES THE PROVISIONS OF THIS

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD06205-01-1

S. 1834                             2

SECTION BY SELLING, OFFERING TO SELL OR GIVING AWAY AS EITHER  A  RETAIL
OR  WHOLESALE  PROMOTION ANY PRODUCT WHICH CONTAINS A SYNTHETIC CANNABI-
NOID, SHALL BE SUBJECT TO A CIVIL PENALTY OF NOT MORE THAN FIVE  HUNDRED
DOLLARS  PER  VIOLATION,  RECOVERABLE  IN  AN  ACTION BY ANY ENFORCEMENT
AUTHORITY DESIGNATED BY A MUNICIPALITY OR POLITICAL SUBDIVISION  OF  THE
STATE.
  5.  IT SHALL BE A DEFENSE THAT ANY PERSON, FIRM, CORPORATION, PARTNER-
SHIP, ASSOCIATION, LIMITED LIABILITY COMPANY OR OTHER ENTITY THAT  SOLD,
OFFERED  FOR SALE OR GAVE AWAY AS EITHER A RETAIL OR WHOLESALE PROMOTION
ANY PRODUCT WHICH CONTAINS A SYNTHETIC CANNABINOID, DID NOT  HAVE  KNOW-
LEDGE  THAT IT WAS A PRODUCT CONTAINING A SYNTHETIC CANNABINOID, IF SUCH
KNOWLEDGE WAS NOT REASONABLY DISCOVERABLE.
  S 2. This act shall take effect on the sixtieth  day  after  it  shall
have become a law.

co-Sponsors

View additional co-sponsors

2011-S1834A (ACTIVE) - Details

See Assembly Version of this Bill:: A7231
Current Committee:: Senate Rules
Law Section:: General Business Law
Laws Affected:: Add §391-r, Gen Bus L
Versions Introduced in Other Legislative Sessions:: 2009-2010: S7081
2013-2014: A5889

2011-S1834A (ACTIVE) - Summary

2011-S1834A (ACTIVE) - Sponsor Memo

                                BILL NUMBER:S1834A

TITLE OF BILL:
An act
to amend the general business law, in relation to prohibiting the sale
or distribution of products containing a synthetic cannabinoid

PURPOSE:
To prohibit the sale or distribution of any product
containing a synthetic cannabinoid.

SUMMARY OF PROVISIONS:
Section One - The General Business Law is amended by adding a new
section 391-s to define a "synthetic cannabinoid" and prohibits the
sale, offering or gift of any products containing such.
Sets forth a civil penalty for violations of this section. Creates a
defense for persons who unknowingly sell, offer or give away products
containing a synthetic cannabinoid if such knowledge was not
reasonably discoverable.

Section Two - Sets forth the effective date.

EXISTING LAW:
New York State Law does not ban the sale or gift of the herb-like
products that contain synthetic cannabinoids often known as K2, Spike
99, Spice, Yucatan Fire, Genie, Zohai and many others.

JUSTIFICATION:
Many recent news reports have brought to light the use of a legal
herb-like product that is laced with a synthetic cannabinoid that is
being smoked by individuals, including teens, as "fake weed." While
producing a marijuana-like high, dangerous side effects reported
include hallucinations, vomiting, agitation, increased heart rate,
elevated blood pressure and other adverse conditions.

This product, known as K2, Spike 99, Spice, Yucatan Fire, Genie or
Zohai and many others, can often be legally purchased in head shops,
smoke shops, tobacco shops or novelty shops. It can also be legally
purchased by mail or on the Internet. In fact, the product is often
marketed as incense or potpourri and on average sells for $30 to $40
per three gram bag. This price is comparable to what an individual
would pay on the street for the illegal substance marijuana.

Even more disturbing is that this type of synthetic cannabinoid has
never been tested for safety in humans as it was created for
experimental use in animals and cell cultures. In fact, these
synthetic cannabinoids have a chemical structure that is shared with
many cancer-causing agents.

The United States Drug Enforcement Administration (DEA) has issued
intelligence alert bulletins in regard to these substances. In
addition, the chemical compounds outlined in this legislation are on
the DEA's Office of Diversion Control's list of "Drugs and Chemicals
of Concern."


While the synthetic ingredients in these herb-like products which
mimic those of the illegal drug marijuana are banned throughout much
of Europe, bans are only beginning to take place in the United
States. Legislation banning these products recently was signed into
law in Kansas making it the first state in the nation to ban this
type of dangerous product. Legislation is also pending in Kentucky,
Missouri and Tennessee as of March 2010.

LEGISLATIVE HISTORY:
2010:  S.7081A - Reported out of Consumer Protection; Committed
to Codes

FISCAL IMPLICATIONS:
None.

EFFECTIVE DATE:
This act shall take effect on the sixtieth day after it shall
have become a law.

2011-S1834A (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 1834--A

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                            January 13, 2011
                               ___________

Introduced  by  Sens.  FLANAGAN,  AVELLA,  DeFRANCISCO, GOLDEN, KENNEDY,
  LARKIN -- read twice and ordered  printed,  and  when  printed  to  be
  committed  to  the  Committee on Consumer Protection -- recommitted to
  the Committee on Alcoholism and Drug Abuse in accordance  with  Senate
  Rule  6,  sec.  8  --  committee  discharged,  bill  amended,  ordered
  reprinted as amended and recommitted to said committee

AN ACT to amend the general business law, in relation to prohibiting the
  sale or distribution of products containing a synthetic cannabinoid

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The general business law is amended by adding a new section
391-s to read as follows:
  S  391-S.  SALE  OR  DISTRIBUTION  OF  PRODUCTS CONTAINING A SYNTHETIC
CANNABINOID. 1. FOR THE PURPOSES OF THIS  SECTION,  "SYNTHETIC  CANNABI-
NOID" SHALL MEAN ANY OF THE FOLLOWING CHEMICAL COMPOUNDS:
  (A)   CP   47.497   AND   HOMOLOGUES:  2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]
-5-(2-METHYLOCTAN-2-YL)PHENOL);
  (B) HU-210: [(6AR,  10AR)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-  (2-METHY-
LOCTAN-2-YL)-6A,7,10, 10A-TETRAHYDROBENZO[C] CHROMEN-1-OL)];
  (C)     HU-211:     (DEXANABINOL,     (6AS,    10AS)-9-(HYDROXYMETHYL)
-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)-6A,7,10,     10A-TETRAHYDROBENZO[C]
CHROMEN-1-OL);
  (D) JWH-O18: 1-PENTYL-3-(1-NAPHTHOYL)INDOLE; OR
  (E) JWH-O73: 1-BUTYL-3-(1-NAPHTHOYL)INDOLE.
  2.    NO  PERSON, FIRM, CORPORATION, PARTNERSHIP, ASSOCIATION, LIMITED
LIABILITY COMPANY OR OTHER ENTITY SHALL SELL,  OFFER  TO  SELL  OR  GIVE
AWAY,  AS  EITHER  A  RETAIL  OR WHOLESALE PROMOTION, ANY PRODUCT, WHICH
CONTAINS A SYNTHETIC CANNABINOID, WHICH MAY ALSO BE REFERRED TO  AS  K2,
SPIKE  99,  YUCATAN FIRE, SPICE, GENIE OR ZOHAI, EXCEPT AS AUTHORIZED BY
SUBDIVISION THREE OF THIS SECTION.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD06205-02-2

S. 1834--A                          2

  3.  NOTHING  IN  THIS   SECTION   SHALL   APPLY   TO   NONPRESCRIPTION
OVER-THE-COUNTER  DRUGS  APPROVED  OR  REGULATED BY THE FEDERAL FOOD AND
DRUG ADMINISTRATION.
  4.  ANY  PERSON,  FIRM, CORPORATION, PARTNERSHIP, ASSOCIATION, LIMITED
LIABILITY COMPANY OR OTHER ENTITY THAT VIOLATES THE PROVISIONS  OF  THIS
SECTION  BY  SELLING, OFFERING TO SELL OR GIVING AWAY AS EITHER A RETAIL
OR WHOLESALE PROMOTION ANY PRODUCT WHICH CONTAINS A  SYNTHETIC  CANNABI-
NOID,  SHALL BE SUBJECT TO A CIVIL PENALTY OF NOT MORE THAN FIVE HUNDRED
DOLLARS PER VIOLATION, RECOVERABLE  IN  AN  ACTION  BY  ANY  ENFORCEMENT
AUTHORITY  DESIGNATED  BY A MUNICIPALITY OR POLITICAL SUBDIVISION OF THE
STATE.
  5. IT SHALL BE A DEFENSE THAT ANY PERSON, FIRM, CORPORATION,  PARTNER-
SHIP,  ASSOCIATION, LIMITED LIABILITY COMPANY OR OTHER ENTITY THAT SOLD,
OFFERED FOR SALE OR GAVE AWAY AS EITHER A RETAIL OR WHOLESALE  PROMOTION
ANY  PRODUCT  WHICH CONTAINS A SYNTHETIC CANNABINOID, DID NOT HAVE KNOW-
LEDGE THAT IT WAS A PRODUCT CONTAINING A SYNTHETIC CANNABINOID, IF  SUCH
KNOWLEDGE WAS NOT REASONABLY DISCOVERABLE.
  S  2.  This  act  shall take effect on the sixtieth day after it shall
have become a law.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S1834

Share this bill

Sponsored By

Archive: Last Bill Status - In Senate Committee Rules Committee

Bill Amendments

co-Sponsors

2011-S1834 - Details

2011-S1834 - Summary

2011-S1834 - Sponsor Memo

2011-S1834 - Bill Text download pdf

co-Sponsors

2011-S1834A (ACTIVE) - Details

2011-S1834A (ACTIVE) - Summary

2011-S1834A (ACTIVE) - Sponsor Memo

2011-S1834A (ACTIVE) - Bill Text download pdf

Comments